Nephros, Inc. (NEPH)
3.98
+0.21
(+5.57%)
USD |
NASDAQ |
Feb 24, 14:01
Nephros Research and Development Expense (Quarterly) : 0.338M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Apyx Medical Corp. | 0.801M |
| Cerus Corp. | 15.82M |
| Owlet, Inc. | 3.785M |
| Abbott Laboratories | 721.00M |
| Plus Therapeutics, Inc. | 2.436M |